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ABSTRACT Lactate can be produced by many gut bacteria, but in adults its accu-
mulation in the colon is often an indicator of microbiota perturbation. Using contin-
uous culture anaerobic fermentor systems, we found that lactate concentrations re-
mained low in communities of human colonic bacteria maintained at pH 6.5, even
when DL-lactate was infused at 10 or 20 mM. In contrast, lower pH (5.5) led to peri-
odic lactate accumulation following lactate infusion in three fecal microbial commu-
nities examined. Lactate accumulation was concomitant with greatly reduced bu-
tyrate and propionate production and major shifts in microbiota composition, with
Bacteroidetes and anaerobic Firmicutes being replaced by Actinobacteria, lactobacilli,
and Proteobacteria. Pure-culture experiments confirmed that Bacteroides and Firmic-
utes isolates were susceptible to growth inhibition by relevant concentrations of
lactate and acetate, whereas the lactate-producer Bifidobacterium adolescentis
was resistant. To investigate system behavior further, we used a mathematical
model (microPop) based on 10 microbial functional groups. By incorporating differ-
ential growth inhibition, our model reproduced the chaotic behavior of the system,
including the potential for lactate infusion both to promote and to rescue the per-
turbed system. The modeling revealed that system behavior is critically dependent
on the proportion of the community able to convert lactate into butyrate or propi-
onate. Communities with low numbers of lactate-utilizing bacteria are inherently less
stable and more prone to lactate-induced perturbations. These findings can help us
to understand the consequences of interindividual microbiota variation for dietary
responses and microbiota changes associated with disease states.
IMPORTANCE Lactate is formed by many species of colonic bacteria, and can accu-
mulate to high levels in the colons of inflammatory bowel disease subjects. Con-
versely, in healthy colons lactate is metabolized by lactate-utilizing species to the
short-chain fatty acids butyrate and propionate, which are beneficial for the host.
Here, we investigated the impact of continuous lactate infusions (up to 20 mM) at
two pH values (6.5 and 5.5) on human colonic microbiota responsiveness and meta-
bolic outputs. At pH 5.5 in particular, lactate tended to accumulate in tandem with
decreases in butyrate and propionate and with corresponding changes in microbial
composition. Moreover, microbial communities with low numbers of lactate-utilizing
bacteria were inherently less stable and therefore more prone to lactate-induced
perturbations. These investigations provide clear evidence of the important role
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these lactate utilizers may play in health maintenance. These should therefore be
considered as potential new therapeutic probiotics to combat microbiota perturba-
tions.
KEYWORDS lactate, lactate-utilizing bacteria, pH, short-chain fatty acids,
mathematical modeling
The microbial community of the large intestine is known to differ greatly in speciescomposition between individuals. Nevertheless, in healthy individuals the commu-
nity displays a considerable degree of stability in species composition and metabolite
outputs from day to day (1). Meanwhile, interindividual variation is generally more
pronounced at the level of individual species than at the level of phyla or broad
functional groups. This makes it possible for us to ask some generic questions about the
response of the human intestinal microbiota to perturbation. Imposed changes in pH,
for example, have been shown previously to cause broad shifts in metabolite outputs
and species composition in human colonic communities maintained in in vitro contin-
uous culture (2, 3). In vivo, the pH of the intestinal lumen is largely determined by the
concentrations of short-chain acids being produced by the fermentation of dietary fiber
(4). This means that the activities of the gut microbiota have the potential to feed back
on its behavior and species composition by altering the gut environment. Potentially,
this applies not only to pH but also to any effects of individual fermentation acids, or
indeed of other metabolic products, on microbial growth.
In this study, we focus on the potential impact of changes in lactate concentration
and lactate supply upon the colonic microbial community at two different pH values.
Lactic acid is a product of both mammalian metabolism and of gut bacterial fermen-
tation of carbohydrates under anaerobic conditions. Lactate enters the gut from the
bloodstream but is also produced by the gut microbiota in both the small intestine,
where the microbiota is typically dominated by lactic acid-producing bacteria, and in
the colon, which harbors many bacterial species with the potential to produce lactate
among other fermentation products (5).
Lactate has been shown to inhibit the growth of some pathogenic bacteria, includ-
ing Escherichia coli (6), and can also reach high concentrations in the gut of healthy
infants, reflecting the dominance of L-lactate-producing bifidobacteria (7, 8). However,
it can also exert an array of deleterious effects, in particular due to its potential to drive
down gut pH as a result of its low pKa, which can lead to changes in the microbiota
and to acidosis in the adult colon (9). It can also be used as a growth substrate by
sulfate-reducing gut bacteria (10) and so has the potential to promote the formation of
toxic concentrations of hydrogen sulfide, which has been linked to colonic disease (11).
Lactate has also been shown to accumulate in the colon in progressively greater
amounts under conditions of increasingly severe colitis (12, 13) and in the small
intestine microbially produced D-lactate is a neurotoxin that can prove fatal in cases of
short-bowel syndrome (14). Recent work has also revealed that lactate may promote
the growth of certain pathogens such as Salmonella enterica serovar Typhimurium,
which can utilize lactate and therefore benefits from a perturbed gut environment with
lactate accumulation. Indeed, Salmonella infection is reported to suppress formation of
the beneficial short-chain fatty acid (SCFA) butyrate and to increase the production of
L-lactate from glucose by the colonic epithelium (15). Lactate can also enhance immune
evasion by the fungal pathogen Candida albicans by triggering masking of its cell wall
antigens (16).
Rather little is known about the impact of lactate influx, arising either from the small
intestine or from host tissues, upon the colonic microbiota. There is scant information
on lactic acid concentration in the different human intestinal compartments under
normal conditions. However, in pigs, small intestinal lactic acid concentrations have
been reported to be 50 to 100 mM, while the total cumulative concentration of other
SCFAs, such as acetate, propionate, and butyrate, is just 5 mM. In the large intestine,
however, those proportions are reversed (17–19). Importantly, lactate does not appear
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to accumulate in the colon of healthy adult humans either, even though it can be
produced by many gut bacteria. Indeed, concentrations of just 5 to 7 mM lactate have
been reported in the ascending colons of sudden-death victims with around 180 mM
total SCFAs (20).
The reason that lactate does not accumulate in the adult human colon under normal
health conditions, despite being produced by many gut anaerobes, is that the gut
microbiota includes lactate-utilizing bacteria (which we refer to here generically as
“LUB”) that can utilize lactate for growth. The activities of these LUB therefore play an
important role in determining lactate concentrations (21). Prominent lactate utilizers
include particular species of the Firmicutes phylum that are able to produce the SCFAs
butyrate or propionate from lactate (5, 22). Since these two SCFAs are known to exert
a number of positive effects for the host (23), lactate utilization can be considered an
indirectly beneficial consequence of lactate production by other members of the gut
microbiota. However, it is known that some of the previously described lactate-utilizing
species are sensitive to reduced pH, which may help to explain why lactate accumulates
under conditions of a mildly acidic pH but not at a more neutral pH (24, 25). Further
work is required to better understand the potential roles that lactate utilizers may play
in maintaining the healthy adult colon.
Here, we use a combination of experimental and theoretical modeling approaches
to explore the role of lactate and lactate utilization in the stability of gut microbial
communities. Our experimental approach uses pH-controlled anaerobic continuous
cultures inoculated with fecal bacteria and supplied with polysaccharides as growth
substrates. We show that LUB within the gut microbiota have a remarkable capacity to
consume lactate, thereby stabilizing the system, and that systemic pH is a significant
driver of this activity. Theoretical modeling broadly reproduced these changes and is
consistent with hypotheses regarding (i) the selective inhibition of the two major phyla
of commensal gut anaerobes (Bacteroidetes and Firmicutes) by lactate and (ii) the
populations and activities of LUB, which both play key roles in the observed community
shifts. Lactate accumulation is shown here to result in perturbed communities that are
dominated by Proteobacteria and other facultative anaerobes, mirroring changes that
have been reported for microbial community perturbations associated with conditions
such as diarrhea in humans (26).
RESULTS
Impact of fecal inoculum, pH, and lactate infusions on colonic microbiota
present in fermentor vessels. pH-controlled continuous flow fermentor systems, at
either pH 5.5 or 6.5, mimicking the approximate pH of the proximal and distal colons,
respectively (27), were supplied with culture medium containing 0.74% mixed poly-
saccharides and 0.2% peptides, and were inoculated with fecal microbiota (as detailed
in Materials and Methods). Fermentors held at both pHs were continuously infused with
either 20 mM (“high”), 10 mM (“medium”), or zero lactate (which we term “low” rather
than “zero” since there is always a small amount of lactate present in fermentors due
to its continual production by some members of the fermentor microbial community),
in order to monitor the overall impact on the microbial community structure. The
experiment was repeated with three different fecal microbiota donors. The overall
microbiota clustering patterns, based upon bacterial 16S rRNA gene sequence analysis,
showed that fecal donor was the largest driver of clustering patterns, but that pH and
lactate infusions were also important contributors (for all three variables P  0.001,
using the parsimony test in mothur) (see Fig. S1a in the supplemental material). In
agreement, principal-component analysis (PCA) revealed that, although samples clus-
tered by donor (Fig. S1b), the data points derived from samples at pH 5.5 were more
widely distributed throughout the plot, indicating that the lower pH had a greater
destabilizing impact on the microbiota (Fig. 1a). Furthermore, both observed bacterial
operational taxonomic unit (OTU) richness (Fig. 1b) and overall bacterial loads, as
assessed by qPCR (Fig. 1c), were consistently lower in the fermentor vessels maintained
at pH 5.5 than both the original inocula samples and fermentor vessels at pH 6.5. Similar
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initial reductions in OTU diversity have been reported previously (28) and are assumed
to result mainly from the more limited substrate diversity and constant environmental
conditions compared to the situation in vivo. Dead cells derived from higher up in the
gastrointestinal tract, which can still be detected in fecal inocula using DNA-based
methods, may also be a contributing factor, as these will be rapidly washed out of the
fermentor systems as the growth medium is continuously replenished. Our results here
show that the prevailing pH of the system is also crucially important, with the lower pH
clearly limiting the growth of many species.
Having established the importance of pH, we then explored the dynamics within
fermentor systems maintained at the two different pHs separately.
Stability of the microbial community in continuous culture at pH 6.5. The time
course of changes in community composition and metabolism following inoculation at
pH 6.5 are shown in Fig. 2 and Fig. S2a. Short-chain fatty acid concentrations (ranging
from 65 to 110 mM) between two and 4 days were typical of fecal samples from healthy
adults (4). Sequencing analysis at the family-level revealed a steady increase in Bacte-
roidaceae, which accounted for 70% of 16S rRNA gene sequences after 4 days of
incubation at pH 6.5. The dominance of Bacteroidaceae when soluble polysaccharide
substrates are supplied at pH 6.5 agrees closely with fermentor-based experiments
reported previously (2, 3, 29, 30). Full data, including proportional abundance and
taxonomic classification of individual OTUs, are given in Table S1 in the supplemental
material.
Each of these experiments involved two additional, parallel, vessels that received
identical fecal inocula and were continuously infused with medium containing the
same mix of polysaccharides, but which also received in addition a continuous infusion
of either 10 mM (Fig. 2b) or 20 mM DL-lactate (Fig. S2a). Lactate infusion did not greatly
FIG 1 Impact of pH on fecal microbiota composition within continuous culture fermentor vessels. (a) PCA plot showing the impact of
fecal donor and pH on overall microbiota clustering patterns. The text adjacent to each main cluster on the plot indicates the fecal donor
(also visualized in the accompanying Fig. S1b). Samples held at pH 5.5 were more variable than those held at pH 6.5 and the original
inocula samples, which tended to cluster more tightly. (b) Bacterial richness in original fecal inocula samples, and fermentor samples held
at pH 5.5 or 6.5 over the 4-day course of the experiments. (c) Log10 scale 16S rRNA gene counts/ml, as assessed by qPCR, in original fecal
inocula samples, and in fermentor samples held at pH 5.5 or 6.5 over the 4-day course of the experiments. For panels b and c, the center
lines show the medians; the box limits indicate the 25th and 75th percentiles as determined by R software; the whiskers extend 1.5 times
the interquartile range from the 25th and 75th percentiles, with outliers represented by dots; crosses represent sample means; and data
points are plotted as open circles.
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alter either the major metabolite concentrations or microbial community composition
from 48 to 96 h. In addition, LEfSe analysis showed that, overall, no bacterial families,
genera or OTUs were significantly associated with any of the three lactate infusion
levels at pH 6.5 after correcting for the false discovery rate (FDR) (Table S2a). In some
cases, lactate accumulated before 48 h, with a proportionally increased bifidobacterial
population presumably contributing more lactate as a product of polysaccharide
fermentation (Fig. 2; see also Fig. S2a), but lactate concentrations remained low (below
4 mM) after 48 h, indicating efficient lactate utilization by other species within the
community.
Instability of the microbial community in continuous culture at pH 5.5. When
the same experiments were run for the D2 microbiota with the pH held at 5.5, the
proportion of Bacteroides was lower than that observed at pH 6.5, and there was instead
a greater proportion of butyrate-producing Firmicutes species. This was accompanied
by higher butyrate levels than at pH 6.5 in the presence of up to 10 mM lactate (Fig. 3).
These observations were in agreement with previous reports showing that Bacteroides
spp. are less dominant, and that the overall butyrate production is enhanced, in
fermentor systems held at the lower pH (2). For the other two donors (D7 and D19),
however, pH 5.5 with zero lactate infusion caused a dramatic shift to the production of
acetate and lactate, with little or no propionate or butyrate formed. This corresponded
to a greatly increased proportional representation of lactate-producing bifidobacteria
(and lactobacilli in donor D7 only), within the community from days 1 to 4 (Fig. 3a).
Remarkably, infusion of 10 mM lactate at pH 5.5 resulted in lower lactate concentrations
at day 4 in these two donors (Fig. 3b), together with restoration of a community profile
closer to that of the inoculum. Partial restoration of propionate and butyrate formation
at day 4 was also seen with infusion of 20 mM lactate for D19 and in an extended repeat
fermentor run for D2 (see Fig. S2b and Fig. S3a). In the case of D7 with 20 mM lactate
infusion, metabolic activity appeared to be limited to the partial conversion of lactate
to acetate, suggesting that there was little fermentation of the input polysaccharides to
SCFA, but perhaps with possible conversion of one stereoisomer of the input DL-lactate
to acetate (Fig. S3b). There is evidence to suggest that some gut anaerobes might be
able to convert lactate to acetate (see, for example, reference 31), but the taxonomic
FIG 2 Changes in short-chain fatty acid concentrations and relative abundance of bacterial families in continuous flow fermentor communities derived from
three fecal donors (D2, D7, and D19) controlled at pH 6.5. (a) No infusion of lactate; (b) continual infusion of 10 mM DL-lactate.
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groups involved are not fully characterized, and we were therefore not able to
definitively assign this activity to specific taxa in our fermentor experiments.
Despite the apparently chaotic behavior of the system at pH 5.5, repeats of the D2,
D7, and D19 experiments largely gave very similar outcomes (Fig. S3a to c, respectively).
These perturbed metabolic profiles were mirrored by 16S rRNA gene sequence-based
taxonomic results (Fig. 4). While low levels of lactate at pH 5.5 were correlated with
increased proportional abundances of bifidobacteria and Collinsella spp. (Fig. 4a; see
also Table S2b), infusion of higher levels of lactate were correlated with increased
proportional abundances of facultative anaerobes linked to microbiota perturbations
such as Escherichia/Shigella and Enterococcus spp. (Fig. 4a). Furthermore, Spearman
correlation analysis indicated that, overall, facultative anaerobes such as Klebsiella,
Streptococcus, Bacillus, and Enterococcus spp. appeared to be correlated with each other
(Fig. 4b, top left-hand cluster on the dendrograms), likely driven by selective pressure
of the differing lactate concentrations at the lower pH.
Absolute bacterial numbers, populations of presumptive lactate-utilizing bac-
teria, and methanogenic archaea. Total bacterial numbers and populations of metha-
nogenic archaea were estimated by qPCR; results from D2 are shown in Fig. 5 and those
from donors D7 and D19 in Fig. S4a and b, respectively. Also shown are the populations
of bacteria related to Anaerobutyricum (formerly Eubacterium [32]) hallii, Anaerostipes
hadrus, and Negativicutes, all of which are bacterial lineages that have previously been
demonstrated to include lactate-utilizers and which were estimated using group-
specific qPCR primer sets. Methanogens were only abundant in fecal samples from D2,
but it can be noted that their populations were maintained in the fermentors run at pH
6.5 with 0, 10, or 20 mM lactate infusion. At pH 5.5, however, methanogen populations
were only maintained when there was no lactate infusion (Fig. 5).
Sequence read counts corresponding to these LUB were broadly in accordance with
the data obtained by qPCR (see Table S2). Proportional abundances of OTUs 0063 and
0073, both corresponding to A. hallii, and OTU0034 (A. hadrus) increased on average
concomitantly with lactate concentrations at pH 6.5. Although LEfSE P values for all of
these OTUs were low (P  0.007, 0.005, and 0.001, respectively), none were deemed
significant after correction for the FDR using the Benjamini-Hochberg method (Ta-
ble S2a). Other potential lactate-utilizers were not detected in all three fecal microbiota
FIG 3 Changes in short-chain fatty acid concentrations and relative abundance of bacterial families in continuous flow fermentor communities derived from
three fecal donors (D2, D7, and D19) controlled at pH 5.5. (a) No infusion of lactate; (b) continual infusion of 10 mM DL-lactate.
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donor samples, but included OTU0157, corresponding to Coprococcus catus, that was
proportionally enriched with lactate infusion in the D2 and D7 experiments, and
Veillonella spp. that increased in the D7 experiment between 2 and 4 days at pH 6.5
(Table S2a). The behavior of LUB at pH 5.5 (Table S2b) was complicated by the effects
of lactate growth inhibition, as discussed below, although increases were seen with
10 mM lactate infusion. Furthermore, LUB populations monitored by qPCR (Fig. S4)
showed some variation between individual donor repeat experiments, which were
performed several weeks apart, perhaps reflecting fluctuations in the initial species
composition of the fecal inocula over time.
Selective growth inhibition by lactate. The growth of representative strains of
Bifidobacterium adolescentis, Eubacterium rectale, Faecalibacterium prausnitzii, and Bac-
teroides thetaiotaomicron was examined in pure culture with 10 mM glucose in the
presence of 5 to 40 mM DL-lactate, either in the presence or absence of 30 mM acetate
(Fig. 6). These experiments demonstrated different growth responses of the four
species to lactate and acetate, and the results may help to explain the microbial
community shifts observed in the fermentor experiments shown in Fig. 2 and 3. Growth
of B. thetaiotaomicron at pH 6.5 was inhibited by concentrations of lactate of 10 mM or
more, and growth inhibition was increased by the presence of 30 mM acetate. In
contrast, growth of B. adolescentis was unaffected by lactate or acetate at either pH.
Growth of E. rectale and F. prausnitzii in the presence of 30 mM acetate (required for
optimal growth of these species) showed little effect of lactate up to 40 mM at pH 6.5
but was progressively decreased at pH 5.5.
Theoretical modeling of the human colonic microbial community. In order to
gain better understanding of the factors underlying the shifts in microbiota composi-
FIG 4 (a) LEfSe results showing the genera that were significantly associated with different lactate infusion levels at pH 5.5. All P values were 0.05 after
correction for FDR. (b) Spearman correlation network for bacterial genera in the fermentor systems at pH 5.5. Correlations were based on data from all donors,
including repeat fermentor runs. In order to focus on the most abundant genera, only reads that occurred more than five times, and which were detected in
at least 10% of samples, were included in this comparison. A total of 57 samples, encompassing all pH 5.5 fermentor samples collected after the 24-h time point,
were included in both of these comparisons. Samples from the earlier time points were excluded as they more reflect the composition of the initial fecal inocula
rather than the communities that had adapted to the conditions inside the fermentors.
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tion and metabolites, we decided to apply the theoretical modeling approach devel-
oped by Kettle et al. (33) with slight modifications (see Materials and Methods) in
parameter values. This model has now been made publicly available in the language R
under the name microPop (34). The model, as applied to the human colonic microbiota,
is based on the assumption of 10 microbial functional groups (MFGs; M1 to M10) whose
substrate preferences, metabolic outputs, and responses to pH are all numerically
defined. For further details about the model, see “Mathematical model” in Materials and
Methods. Group M1 was taken to include all Bacteroidetes sequences while M4 (lactate
producers) included all bifidobacteria and lactobacilli. Firmicutes were then split be-
tween four non-butyrate-producing groups (M2, M3, M7, and M9) and three butyrate-
producing groups (M5, M6, and M8), as detailed in Table 1. Of these, only M7
(Negativicutes and Coprococcus catus) and M8 (A. hallii and Anaerostipes spp.) are
assumed to be able to utilize lactate. The proportion of group M10 (methanogens) was
based on estimates from qPCR (see Table S3a).
Assumed maximum growth rates and pH responses used in the modeling are shown
in Tables S3b and c, and stoichiometries are shown in Table S3d. Based on the pure
culture experiments shown in Fig. 6, the model was modified to include noncompet-
itive inhibition of M1 (Bacteroidetes) by lactate (assumed Ki  5 mM) both at pH 6.5 and
5.5, and noncompetitive inhibition by lactate of all other groups apart from M4 (lactate
producers such as bifidobacteria, assumed Ki  15 mM) at pH 5.5, but not at pH 6.5 (see
Table S3e). This modification provided a good simulation of the microbiota and
metabolite changes observed experimentally with and without lactate infusion (Fig. 7
and 8). Since there is only limited information on the inhibition of LUB by lactate (35),
we assumed the same Ki for groups M7 and M8 as for most other groups of Firmicutes.
An alternative assumption of no inhibition of these two groups by lactate did not affect
their modeled populations greatly but did improve lactate utilization and caused
predicted changes in other MFGs, notably M1, M4, and M5 (see Fig. S5a and b).
Importantly, simulation was very poor if no lactate inhibition was assumed, further
indicating the critical role of lactate on overall microbial community dynamics (Fig. S5c).
FIG 5 Changes in 16S rRNA gene count estimated by qPCR for three groups of lactate-utilizing Lachnospiraceae, total bacteria and methanogenic archaea in
fermentors inoculated with D2 microbiota at pH 6.5 (a) and at pH 5.5 (b).
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Simulations at pH 6.5 predicted the dominance of Bacteroides (M1) that was ob-
served both in these experiments and in previous experiments (2, 3, 29) (Fig. 7). As
explained previously (33), the impact of lower pH is effectively modeled by assuming
a lower tolerance of mildly acidic pH for Bacteroidetes (group M1) compared to
Firmicutes (groups M2, M3, M5, M6, M7, M8, and M9) or lactic acid bacteria, including
bifidobacteria (M4). These pH responses (Table S3c) are based broadly on the experi-
mental data of Duncan et al. (30). For the D2 experiments, these assumptions led to a
decrease in the dominance of M1 (Bacteroidetes) when the pH shifted to pH 5.5, as
noted previously (2, 33) (Fig. 8). It should be mentioned that we did not build an initial
growth lag after inoculation into our modeling, although this could plausibly occur
after the introduction of non-actively growing cells from fecal inocula into the fermen-
FIG 6 Growth (OD650) of four bacterial strains representing mathematical modeling microbial functional groups (MFGs) 1, 4, 5, and 6 in pure culture in YCFAG
(10 mM glucose) medium containing different concentrations of lactate, with or without 30 mM acetate. B. theta, Bacteroides thetaiotaomicron; F. prau,
Faecalibacterium prausnitzii; B. ado, Bifidobacterium adolescentis; E. rec, Eubacterium rectale.
TABLE 1 Microbial functional groups used for model simulationsa
MFG Description Taxa included
M1 Propionate producers Bacteroidetes
M2 Starch degrading acetate producers Ruminococcus bromii
M3 Acetate producers (nonacetogenic) Lachnospiraceae plus Ruminococcaceae (minus M2, M5, M6, M8, and M9)
M4 Lactate producers Actinobacteria, Lactobacillaceae, Enterococcaceae, Streptococcaceae, and Peptococcaceae
M5 Butyrate producers 1 Roseburia spp. (plus Eubacterium rectale)
M6 Butyrate producers 2 Faecalibacterium plus Subdoligranulum
M7 Lactate utilizers producing propionate Negativicutes plus Coprococcus catus
M8 Lactate utilizers producing butyrate Anaerostipes spp. plus Anaerobutyricum spp.
M9 Acetogens Blautia spp.
M10 Methanogens Methanogenic archaea
aMFG, microbial functional group.
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tor medium. Such a growth lag might explain why the initial surge of M1 in the model
runs was not observed experimentally.
Predicted impact of initial microbiota composition, including the presence of
lactate-utilizing bacteria, on the stability of the microbial ecosystem. Variation in
the experimental inocula between the three donors had little impact when modeled at
pH 6.5 with no infusion of lactate (see Fig. S6), as was also observed in the actual
fermentor experiments shown in Fig. 2a. The presence or absence of methanogens in
the inoculum was also predicted to have relatively little impact, except on the levels of
formate (Fig. S7). With lactate inhibition included in the model (see above), we found
that progressively decreasing the proportion of the two groups of LUB (M7M8)
bacteria in the D2 community resulted in a failure to utilize lactate and caused a
dramatic community shift, similar to that observed experimentally (Fig. 9). Decreasing
the theoretical LUB population resulted in a switch toward a lactate-producing (M4)-
dominated microbiota with a concomitant accumulation of lactate. This is likely to
reflect the changing balance between the initial rates of lactate production and
utilization, which together determine the lactate concentration and therefore the
relative growth rates of lactate producers and lactate utilizers.
In summary, our interpretation of the experimental data is as follows. For D2 inocula,
we hypothesize that the initial lactate-utilizing activity was sufficient to prevent an
excessive early increase in lactate within the fermentor at pH 5.5, and the system shows
a balance of metabolite formation somewhat similar to that seen at the higher pH (6.5).
The lower LUB activity within the D7 and D19 inocula may be part of the explanation
for the pH dependent ability of these communities to utilize lactate in the absence of
lactate infusion, as discussed below. Interestingly, the reversal of microbiota perturba-
tions at some points by infusion of 10 mM lactate was also predicted by the model. This
may be explained by stimulation of certain LUB populations by the presence of
noninhibitory concentrations of lactate.
FIG 7 Simulating changes in microbiota composition and metabolite concentrations in fermentor experiments with D2 inocula at pH 6.5. (a) Assuming
no lactate infusion; (b) assuming 10 mM continual lactate infusion.
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The deleterious phenomenon of lactic acidosis has long been recognized in the
rumen and in monogastric farm animals (36). Acidosis is generally triggered by dietary
change, resulting in the replacement of a microbial community dominated by obligate
anaerobic bacteria with one dominated by lactic acid bacteria (37). In ruminants it is
considered that the promotion of lactate-producing bacteria such as Streptococcus
bovis by high-starch diets results in a rise in lactate concentrations that decreases
rumen pH as a result of the low pKa of lactic acid. This rapidly inhibits the growth of
many obligate anaerobes, including lactic acid-utilizing bacteria (LUB) and creates
conditions that further favor lactic acid producers. Similar events can occur in the
human intestine, as for example in the extreme case of short bowel syndrome (38, 39).
We found previously in in vitro batch culture incubations with human fecal inocula,
that an initially low pH (5.2) abolished production of butyrate and propionate, with
lactate and acetate becoming the major products, whereas production of propionate
and butyrate occurred with little or no lactate accumulation when the initial pH was set
at pH 5.8 or 6.5 (24). Here, in continuous culture, pH 5.5 resulted in suppression of
butyrate and propionate formation for two of the three fecal microbiota donors
examined. However, the present investigations reveal that acidic pH is not the only
factor involved in lactate-induced microbial community perturbation. Our results indi-
cate that lactate can exert a selective antimicrobial effect at concentrations as low as
5 mM. Lactic acid bacteria are themselves relatively insensitive to lactate, as might be
anticipated (40). Previous work has also demonstrated that certain Proteobacteria
species, including some pathogens such as Salmonella Typhimurium, are able to
effectively utilize lactate for growth (15). On the other hand, growth of representatives
of the normally dominant Bacteroidetes and Firmicutes phyla was found here to be
highly sensitive to lactate. The growth of B. thetaiotaomicron, for example, was inhib-
ited in pure culture at pH 6.5 by 5 mM lactate in the presence of 30 mM acetate (Fig. 6).
FIG 8 Simulating changes in microbiota composition and metabolite concentrations in fermentor experiments with D2 inocula at pH 5.5. (a) Assuming no
lactate infusion; (b) assuming 10 mM continual lactate infusion.
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In contrast, Bacteroides dominated the fermentor communities supplied with lactate at
pH 6.5 (Fig. 2), but this was in the absence of lactate accumulation, which we assume
was prevented by the activity of LUB. The consequences of lactate inhibition for the
fermentor community became evident at pH 5.5, however, when more groups were
affected and LUB activity may be compromised. Lactate inhibition therefore explains
why the accumulation of lactate can lead to a rapid shift in overall microbiota
community composition from a community that was dominated by Bacteroides and
Firmicutes to one dominated by lactic acid bacteria and Proteobacteria, as observed
here. This interpretation is also strongly supported by the theoretical modeling per-
formed here, which was found to reproduce the behavior of the observed fermentor
microbial communities only when lactate inhibition was assumed.
It would seem obvious that infusion of lactate should further destabilize the
microbiota, and this was indeed observed initially. On the other hand, 10 mM lactate
infusion led to subsequent recovery of butyrate and/or propionate production by day
4 at pH 5.5. This apparent conundrum can, however, be understood if we consider the
populations of LUB within the community. A crucial role for LUB in community stability
is predicted by the theoretical modeling performed here (Fig. 9). First, we could show
that a relatively small population of LUB appears to be sufficient to convert lactate
infused at up to 20 mM into SCFAs and thereby prevent acidosis, provided that the pH
remains close to neutrality. Much lower populations of LUB however resulted in a
failure of lactate-utilization at pH 5.5, even with no infusion of lactate. Similarly, in our
fermentor experiments, LUB populations did not decline when the pH was held at 6.5,
but some dramatic decreases were seen with the pH at 5.5. This behavior was
complicated by donor variation and the possible promotion of some groups by lactate
infusion. We note, however, that the D2 experiments showed no decrease in LUB
populations at pH 5.5 (with no lactate infusion) and no accumulation of lactate.
Whereas the D7 and D19 experiments showed decreased LUB and lactate accumulation
FIG 9 Simulation results showing effect of varying the proportional abundance of lactate-utilizers within the microbiota upon community stability and
metabolite profiles at pH 5.5, assuming no additional lactate infusion, only production by the endogenous microbiota. (a) Assuming lactate utilizers at 0.2%
of the total microbial community; (b) assuming lactate utilizers absent.
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at pH 5.5, even with no lactate infusion. Interindividual variation in these functional
groups of bacteria within the colonic microbiota is therefore likely to be a critical factor
determining the stability of the whole community and its metabolic outputs. The
growth responses of different LUB species to pH and to lactate will clearly merit more
detailed experimental investigation in the future.
Remarkably, these communities often showed the ability to recover from the
perturbed microbiota state when lactate infusion was maintained. This behavior was
seen with all three fecal microbiota studied when supplied with 10 mM lactate and can
probably be explained by increased lactate utilization resulting from selection for LUB.
In the D7 experiments, recovery coincided with increased proportional abundance of
Veillonella within the community after 2 days. It is less clear which LUB were involved
in the case of D2, although A. hadrus and C. catus were proportionally increased at 48 h.
It is important to stress, however, that we are not currently able to identify all LUB only
from 16S rRNA gene sequences or genome sequences. There are likely to be uniden-
tified LUB within the community, while conversely some strains belonging to taxa
known to contain LUB may lack the activity. The identification of LUB activity must
therefore be considered inexact at present. Information is particularly scarce for Nega-
tivicutes from the human colon, although there are many constituent taxa, such as
Megasphaera, Phascolarctobacterium and Veillonella, that have previously been shown
to be able to utilize lactate in order to produce propionate (22).
In addition, many Proteobacteria, including potential pathogens such as Salmonella
(15) and sulfate-reducing bacteria (10), are known to utilize lactate. Lactate utilization
by Proteobacteria is so far reported to involve oxygen, nitrate, or sulfate as terminal
electron acceptors, although increases in Proteobacteria were observed in this study
under anaerobic conditions. Salmonella infection is reported to alter host cell metab-
olism resulting in increased supply of lactate, nitrate, and oxygen from host tissues,
allowing Salmonella Typhimurium to exploit lactate as an energy source for growth in
the gut (15). At the same time, Salmonella infection is accompanied by decreased
supply of butyrate, a regulator of host cell metabolism, from the colonic microbiota
(41). While this suppression of butyrate-producing bacteria may be due in part to host
immune responses (42), our present findings indicate that the impact of increased
lactate influx upon the microbiota is also likely to be a key factor. Thus, increased lactate
and decreased butyrate production are likely to combine to promote highly deleterious
outcomes, including the promotion of pathogens and the production of toxic hydrogen
sulfide (10, 16, 43). In the absence of pH control, the low pKa of lactate tends to
decrease the colonic pH, which in turn tends to further promote microbial lactate
production (24).
This analysis represents an important extension of our theoretical model of the
human colonic microbiota previously described in Kettle et al. (33) using microPop (34).
By incorporating selective inhibition by lactate into the model, we have been able to
predict chaotic behavior in the system when challenged by an inhibitor supplied
externally or generated endogenously. It is easy to see that the same equations can be
readily applied in the future to considering the effects of other inhibitors such as bile
acids and antibiotics as soon as the necessary information on selective inhibition of
different microbial groups is available. The value of theoretical modeling for both
predicting and explaining shifts in microbiota composition and metabolism has been
illustrated here.
In conclusion, we have presented new experimental and theoretical evidence here
that establishes the combined major impact of pH, lactate concentration, and the
presence of LUB on the stability of human gut-derived microbial communities. Lactate
appears to be an important “tipping element” (44) in the colonic ecosystem, particularly
under conditions of lower pH. Increasing lactate concentration can promote a major
switch in community composition and metabolite outputs, in which the sensitivity of
different bacteria to decreasing pH and to lactate growth inhibition are both key
factors. These findings are also highly relevant to the rumen, where lactate production
and utilization has been shown to be a key factor not only in acidosis but also in
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differences between high and low productivity (and low- and high-methane-
producing) animals (45, 46). Importantly, this work also highlights the potential for
using LUB as novel therapeutic probiotics with the aim of restoring healthy microbiota
composition and metabolism in perturbed states in humans. Anaerobutyricum (formerly
Eubacterium) hallii has already been used experimentally as a therapeutic in a mouse
model (47), but the potential of other (perhaps multiple) commensal LUB also appears
to be well worth exploring. Improving our knowledge of the bacterial populations
responsible for lactate utilization appears to be crucial to understanding interindividual
differences in gut microbiota stability and responses to perturbations.
MATERIALS AND METHODS
Bacterial strains, growth medium, and conditions. Four bacterial strains were tested for their
ability to grow and utilize DL-lactate when added to growth medium with two initial pH values (pH 6.5
and pH 5.5). The four strains tested included Bacteroides thetaiotaomicron B5482 (DSM2079T) from
Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ). The other strains (Faecalibacterium
prausnitzii A2-165, Bifidobacterium adolescentis L2-32, and Eubacterium rectale A1-86) were all isolated at
the Rowett Institute, University of Aberdeen. Cultures for growth studies were prepared by growing the
inoculum on M2GSC medium (48) for 20 to 24 h at 37°C under CO2.
Monococulture incubations. Batch culture incubations were performed using anaerobic YCFA
medium as described by Lopez-Siles et al. (49). The medium was adjusted to give two initial start pH
values of 6.5  0.1 and 5.5  0.1 and dispensed in 7.5 ml volumes into Hungate tubes under a stream of
CO2. The medium was heat sterilized at 121°C (15 min) prior to inoculation. The medium contained
glucose (10 mM), either with or without 30 mM acetate and variable levels of lactate (0, 5, 10, 20, and
40 mM). After the medium was cooled, heat-labile vitamins were added. The tubes of medium were
inoculated with 75 l of overnight cultures pregrown in M2GSC medium. After inoculation, triplicate
replicates of the tubes were incubated up to 48 h at 37°C in a water bath. Growth was determined using
a spectrophotometer to monitor the optical density at 650 nm (OD650).
Human colonic microbiota in continuous culture. Single-stage fermentor systems were prepared
largely as described previously (29) with a growth medium based on that of Macfarlane et al. (50). The
carbon sources present in the mixed substrate medium were potato starch (0.5%) with lesser amounts
of xylan, pectin, amylopectin, and arabinogalactan (each provided at 0.06% final concentration) and 0.2%
peptides. To support the growth of species with a metabolic requirement for acetate (e.g., many LUB, as
well as Roseburia and Faecalibacterium species), this SCFA was also added to the feed vessels at a
concentration of 30 mM. For each individual set of fermentor runs, three parallel fermentors were
provided with a final concentration of either 10 mM (“medium”) or 20 mM (“high”) DL-lactate in the feed
vessels (or no added lactate as a control [“low”]). The volume of the fermentor culture vessel was kept
constant at 250 ml, with an exchange of fresh growth medium of the same volume, which equates to one
turnover per day, giving a dilution rate of 0.042 h1. All fermentors were maintained at a constant
temperature of 37°C throughout the experiments using a thermal jacket. Separate experiments were also
conducted at which the pH was kept constant at either pH 5.5  0.2 or pH 6.5  0.2.
The fermentor vessels were inoculated with mixed human fecal microbiota, which was prepared by
mixing fresh feces in 50 mM phosphate buffer containing 0.05% cysteine (pH 6.5) under CO2 to give a
final concentration of 20% (wet weight/vol). The inoculum was added to the fermentor vessels to give
a final concentration of 2% (wt/vol) feces. The experiments were replicated with fecal samples provided
by three different healthy donors (donor 2, donor 7, and donor 19). Two of the donors were female
(donors 2 and 19; aged 54 and 53 years old, respectively), and donor 7 was male, aged 64 years old. The
donors consumed a habitual western style diet and had not taken antibiotics in the 3 months prior to
providing the samples. Ethical approval for the sample collection was provided by the Rowett Institute’s
internal ethical review panel (study number 5946). Samples were collected from the initial fecal inocula
(ino) and from the fermentor vessels just after inoculation (t0/0h), 8 h after inoculation (8h), 24 h after
inoculation (1d), and then daily thereafter at 24-h intervals through day 4 (2d, 3d, and 4d). It should be
noted that the t0/0h measurements for acetate and lactate were typically at slightly lower concentrations
than included in the feed vessels due to initial dilution of fermentor contents as a result of addition of
fecal slurry and/or of buffer solutions to stabilize starting pH. Thereafter, and for the duration of the
experiments, vessels were continuously infused with 30 mM acetate and the various concentrations of
lactate as described above.
DNA extractions and PCR amplification from fermentor samples. Aliquots (460 l) of samples
collected from the model fermentor system were centrifuged at 10,000  g for 10 min to pellet bacterial
cells, and the pellet was then resuspended in 460 l of PBS-glycerol buffer (containing 20% glycerol).
Samples were stored at –20°C until DNA was extracted, at which time samples were thawed on ice, and
the contents transferred to a FastDNA Spin kit lysing matrix E tube. Sodium phosphate buffer and MT
buffer were added to the tubes, and DNA was extracted according to manufacturer’s instructions (MP
Biomedicals, Illkirch, France). DNA was eluted in 50 l of FastPrep elution buffer.
PCR amplification of 16S rRNA genes and Illumina MiSeq sequencing. The extracted DNA was
used as a template for PCR amplification of the V1-V2 region of bacterial 16S rRNA genes using the
barcoded fusion primers MiSeq-27F (5=-AATGATACGGCGACCACCGAGATCTACACTATGGTAATTCCAGMG
TTYGATYMTGGCTCAG-3=) and MiSeq-338R (5=-CAAGCAGAAGACGGCATACGAGAT-barcode-AGTCAGTCA
GAAGCTGCCTCCCGTAGGAGT-3=), which also contain adaptors for downstream Illumina MiSeq sequenc-
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ing, as described previously (3). Each of the samples was amplified with a unique (12-base) barcoded
reverse primer.
PCR amplification was undertaken with Q5 High-fidelity DNA polymerase (New England BioLabs).
Each reaction mix contained DNA template (1 l), 5 Q5 buffer (5 l), 10 mM deoxynucleoside triphos-
phates (0.5 l), 10 M F primer (1.25 l), 10 M R primer (1.25 l), Q5 Taq (0.25 l), and molecular-grade
nuclease-free water (15.75 l) to a final volume of 25 l. The PCR amplification conditions were as
follows: 2 min at 98°C; 20 cycles of 30 s at 98°C, 30 s at 50°C, and 90 s at 72°C; ending with 5 min at 72°C
and then a holding temperature at 10°C. Four PCRs were prepared for each DNA sample, and the
quadruplicate reactions were pooled, ethanol precipitated, and quantified using a Qubit 2.0 fluorometer
with a Qubit HS assay kit (Life Technologies, Ltd.). A sequencing master-mix was created using equimolar
concentrations of DNA from each sample. Sequencing was carried out on Illumina MiSeq machines, using
a 2  250-bp read length, at the Wellcome Sanger Institute (Cambridgeshire, UK) and the Centre for
Genome Enabled Biology and Medicine (CGEBM; Aberdeen, UK).
Analysis of 16S rRNA gene sequencing data. The sequences obtained were analyzed using the
mothur software package (51), with the forward and reverse reads first assembled into paired read
contigs. Any paired contigs that were shorter than 270 bp, longer than 480 bp, contained ambiguous
bases or contained homopolymeric stretches of longer than 7 bases were then removed. Unique
sequences were grouped together and aligned against the SILVA reference database provided at the
mothur website (https://mothur.org/wiki/Silva_reference_files). In order to reduce the impact of se-
quencing errors, preclustering (diffs  3) was performed, and all reads that occurred less than three times
across the entire data set were also removed. Reads classified as either chloroplast, mitochondria,
eukaryote, or unknown sequences were removed from the data set, and then OTUs were generated at
a 97% similarity cutoff level. All samples were rarefied to 7,095 reads to ensure equal sequencing depth
for all comparisons (the median Good’s coverage estimate at this sequencing depth was 98.6% [range,
96.6 to 99.8%]). The final OTU-level results are shown in Table S1 in the supplemental material. OTU
richness and Shannon and Inverse-Simpson diversity indices were calculated for each sample using
mothur. Boxplots were created using BoxPlotR (52). Overall community clustering patterns were calcu-
lated by creating a Bray-Curtis dendrogram in mothur, which was visualized using iTOL (53). Significance
was tested using the Parsimony command in mothur (n  160 samples included in this analysis). To
further visualize microbiota compositional differences between different donors and pHs, principle-
component analysis (PCA) was conducted using only OTUs with a minimum 0.01% relative abundance
(335/3,489 OTUs) using the online web portal Calypso, version 8.84 (54). OTU data were normalized using
total sum normalization (TSS) and then transformed using cumulative-sum scaling and log2 transforma-
tion. Cumulative-sum scaling (CSS) is a widely used method for normalizing microbial community
compositional data. CSS corrects bias introduced by TSS (55). In Calypso, if CSS is selected, TSS
normalized data are also log2 transformed to account for the nonnormal distribution of taxonomic
counts data.
LEfSe (56) and Spearman correlation analyses to assess associations between different lactate
infusion levels and microbiota composition at the two different pHs were carried out using Microbiome-
Analyst (57). LEfSe generates both a P value and a Linear Discriminant Analysis (LDA) score, the latter as
a guide to effect size. For completeness, we have reported both values for every taxa listed in Tables S2a
and b in the supplemental material. A false discovery rate adjustment (Benjamini-Hochberg, using
MicrobiomeAnalyst) was applied to the LEfSe P values, to reduce the risk of identifying false positives due
to multiple comparisons. For the purposes of the LEfSe and Spearman correlation analyses, time was not
considered as a factor, and the four different time points for each donor were instead classified into
either “high,” “medium,” and “low” lactate groups.
Quantitative real-time PCR analysis. The DNA extractions for 16S rRNA gene sequencing were also
used to generate qPCR results. qPCR was carried out as described previously (58), according to the
following modifications: a total of 2 ng DNA, as determined using a Qubit 2.0 fluorometer (Life
Technologies, Ltd.), was used per reaction for most samples. Low concentration samples were diluted 1:1
in herring sperm DNA, and 2 l was added to the reaction. The final concentrations per reaction for the
low concentration samples were as follows (all values are ng of DNA): D7_H_1d_5_5, 0.15; D7_H_2d_5_5,
0.34; D7_H_3d_5_5, 1.07; D7_H_4d_5_5, 2.44; D7_Rpt_M_5_5_0h, 0.71; D7_Rpt_M_5_5_2d, 0.98;
D7_Rpt_H_5_5_0h, 1.98; D19_Rpt_L_5_5_2d, 2.08; and D19_Rpt_L_5_5_4d, 2.18). These variable input
concentrations were factored into the final calculations of 16S rRNA gene copy numbers per sample
volume.
Short-chain fatty acid and lactate determinations. The SCFA and lactate content of batch culture
and fermentor samples were determined by capillary gas chromatography analysis after conversion to
t-butylmethylsilyl derivatives (59). The lower limit for reliable detection of SCFA changes was 0.2 mM.
Mathematical model. The theoretical modeling approach developed previously by Kettle et al. (33)
was applied, using the freeware R library microPop (34). The model, as applied to the human colonic
microbiota in a continuous fermentor setting, is based on the assumption of 10 microbial functional
groups (MFGs, M1 to M10) whose substrate preferences, metabolic outputs and responses to pH are all
specified based on current microbiological knowledge. These relationships are captured in suitable
mathematical formulations, which then form part of a system of ordinary differential equations (ODEs;
full details in Kettle et al. [33]). Furthermore, within each MFG, 10 “strains” were generated whose
characteristics were allowed to vary stochastically within a narrow range of the predefined group
characteristics, resulting in a microbial community initially of 100 “strains.” For given fermentor condi-
tions (such as flow rates, medium composition and pH control) and given initial microbial composition,
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the ODE system was then solved numerically using the R library microPop (34) to simulate how the
microbial community evolves over time.
Initial bacterial community composition (see Table S3a in the supplemental material) was estimated
from the 16S rRNA gene sequence data for the fecal inoculum samples (Table S1). Populations of
methanogens (group M10) were estimated by qPCR rather than 16S rRNA gene sequence data (Ta-
ble S3a), since these were not detected using the 16S rRNA gene PCR primers. Group M1 was taken to
include all Bacteroidetes sequences, while M4 (lactate producers) included all bifidobacteria and lacto-
bacilli and M10 methanogens. Firmicutes were then split between the four non-butyrate-producing
groups M2, M3, M7, and M9 and the three butyrate-producing groups M5, M6 and M8, as detailed in
Table 1. Of these, only M7 and M8 are assumed to be able to utilize lactate. The remaining sequences
that could not be readily assigned to these groups (7 to 16%) were arbitrarily distributed between the
nine bacterial MFGs in proportion to the abundance of each group. These included the Proteobacteria,
which in view of their diversity and metabolic flexibility were not assigned to a single MFG. Populations
of methanogens (group M10) were estimated by qPCR. For D7 and D19, methanogen populations in the
inocula were very low and 0.1% of microbial biomass was assigned to the group M10. For D2, however,
higher levels were detected, and the value of 0.6% was used for M10 in the inoculum.
Microbial parameters were modified slightly from those given in Kettle et al. (33). Assumed maximum
growth rates and pH responses are shown in Table S3b and 3c, and stoichiometries in Table S3d. Two
minor changes were made that simplify alternative pathway stoichiometries (Table S3d). First, a single
stoichiometry is assumed for M5 (4 hexose plus 2 acetate give rise to 5 butyrate, 6 H2, 8 CO2 and 2 H2O).
Second, only two of the three stoichiometries given by Kettle et al. (33) are assumed here for M9. Some
adjustments were made to the maximum growth rates and pH responses assumed for the various MFGs
in order to approximate the observed representation of the major MFGs (Table S3b and c). Half-
saturation constants, which is the substrate concentration at which half the maximum growth rate is
achieved, were set at 0.001 g/liter for all MFGs and all substrates. To generate a microbial population,
within each MFG 10 strains were generated whose maximum growth rates (Table S3b) and half-
saturation constants varied randomly within 10% of the predefined group values, and their pH curves
(Table S3c) were allowed to shift randomly by up to 0.2 U.
For the simulated experimental parameters, vessel turnover was set to 1/d. The medium comprised
protein at 2 g/liter, starch at 5.6 g/liter, nonstarch polysaccharides at 1.8 g/liter, and 32 mM acetate.
Lactate concentration in the medium was set to either 0 or 10 mM. The amount of substrate in the vessel
at time zero was assumed identical to that of the medium. It was assumed that the vessel was seeded
with 2 g/liter of inoculum, with its composition based on 16S rRNA gene sequence data (see Table S3a).
The model was extended to allow for selective bacterial growth inhibition in the presence of lactate.
This was achieved by multiplying the growth rate by a growth suppression factor, which was modeled
as Ki/(Ki  L), where L is the lactate concentration (mM) in the vessel. Ki is the lactate concentration at
which growth is inhibited by 50% (see Table S3e) and was derived from experimental data (see above).
All model results are presented as the average of 10 simulation runs. The biomass of each MFG was
calculated by aggregating the estimated biomass of the individual strains in the corresponding MFG.
Data availability. Sequence data have been deposited in the European Nucleotide Archive and are
available under study accession number PRJEB35259 and sample accession numbers ERS4125408 to
ERS4125571 (see Table S1 in the supplemental material).
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